How much monitoring?

British Journal of General Practice

Volumn 57, Issue 538, 2007, Pages 350-351

  Glasziou, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; HEMOGLOBIN A1C; LITHIUM; ORAL ANTIDIABETIC AGENT; THYROTROPIN; UREA;

ARTERIAL PRESSURE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE CONTROL; DRUG COST; EDITORIAL; GENERAL PRACTICE; HEALTH CARE COST; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LUNG FUNCTION TEST; META ANALYSIS; PATIENT MONITORING; PRESSURE MEASUREMENT; PRIMARY MEDICAL CARE; PROTHROMBIN TIME; SCREENING TEST; SELF MONITORING; SWAN GANZ CATHETER; SYSTEMATIC REVIEW; THYROTROPIN BLOOD LEVEL;

DIAGNOSTIC TESTS, ROUTINE; FAMILY PRACTICE; HUMANS; QUALITY OF HEALTH CARE;

EID: 34248585074     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Vinker S, Kvint I, Erez R, et al. Effect of the characteristics of family physicians on their utilization of laboratory tests. Br J Gen Pract 2007; 57: 377-382.
2. Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ 2005, 330(7492): 644-648.
3. Shah MR, Hasselblad V, Stevenson LW, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomised clinical trials. JAMA 2005; 294: 1664-1670.
4. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355(9210): 1126-1130.
5. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study. J Am Coll Cardiol 2007: doi:10.1016/ j.jacc.2006.10.081.
6. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation a systematic review and meta-analysis. Lancet 2006; 367(9508): 404-411.
7. Coster S, Gulliford MC, Seed PT, et al. Self-monitoring in Type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000; 17(11): 755-761.
8. Farmer A, Neil A. In response to 'variations in glucose self-monitoring during oral hypoglycaemic therapy in primary care'. (Letter.) Diabet Med 2005; 22(4): 511-512.
9. Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. Br J Gen Pract 2004; 54(500): 183-188.
10. Walley T, Duggan AK, Haycox AR, Niziol CJ. Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003; 96(11): 525-531.
11. Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002; 325(7372): 1073-1075.